AD7c-NTP biomarker for Alzheimer's disease

Alzheimer's Reports

Volumn 2, Issue 6, 1999, Pages 327-332

  De La Monte, Suzanne M ^a,c   Ghanbari, Hossein ^a,b   Ghanbari, Kasra ^a,b   Averback, Paul ^a,b   Wands, Jack R ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c Nymox Corporation   (Canada)

Author keywords

AD7C NTP; Alzheimer's disease; Cerebrospinal fluid; Diagnostic assays; Neuronal thread protein urine

Indexed keywords

EID: 22844454467     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Brion JP (1992). The pathology of the neuronal cytoskeleton in Alzheimer's disease. Biochim BiophysActa 1160,134-142.
2. Cabalka L M, Hyman BT, Goodlett CR et al. (1992). Alteration in the pattern of nerve terminal protein immunoreactivity in the perforant pathway in Alzheimer's disease and in rats after entorhinal lesions. Neurobiol Aging 13, 283-291.
3. Chong JK, Cantrell L, Husain M et al. (1992). Automated microparticle enzyme immunoassay for neural thread protein in cerebrospinal fluid from Alzheimer's disease patients. J Clin Lab Anal G, 379-383.
4. de la Monte SM and Bloch KD (1997). Aberrant expression of the constitutive endothelial nitric oxide synthase gene in Alzheimer disease. MolChemNeuropathol30,139-159.
5. de la Monte SM and Wands JR (1992). Neuronal thread protein over-expression in brains with Alzheimer's disease lesions. J NeurolSci 113,152-164.
6. de la Monte SM, Ozturk M and Wands JR (1990). Enhanced expression of an exocrine pancreatic protein in Alzheimer's disease and the developing human brain. J Clin Invest 86,1004-1013.
7. de la Monte SM, Ng SC and Hsu DW (1995). Aberrant GAP-43 gene expression in Alzheimer's disease. Am J Pathol 147, 934-946.
8. de la Monte SM, Carlson Rl, Brown NV and Wands JR (1996a). Profiles of neuronal thread protein expression in Alzheimer's disease. J Neuropathol Exp A/euro/ 55,1038-1050.
9. de la Monte SM, Xu YY, Hutchins GM and Wands JR (1996b). Developmental patterns of neuronal thread protein gene expression in Down syndrome. J Neurol Sci 135,118-125,
10. de la Monte SM, Xu YY and Wands JR (1996e). Modulation of neuronal thread protein expression with neuritic sprouting: relevance to Alzheimer's disease. J Neurol Sci 138,26-35.
11. de la Monte SM, Gamer W and Wands JR (1997a). Neuronal thread protein gene modulation with cerebral infarction. J Cereb Blood FlowMetab 17,623-635.
12. de la Monte SM, Ghanbari K, Frey WH et al. (1997b). Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41 -kD protein in cerebrospinal fluid. J Clin Invest 100,3093-3104.
13. de la Monte SM, Sohn YK and Wands JR (1997c). Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J Neurol Sci 152, 73-83.
14. Ghanbari H, Ghanbari K, Beheshti I er aj. (1998). Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease marker. J Clin Lab Anal 12,285-288.
15. Ghanbari H, Ghanbari K, Munzar M and Averback P (1998). Specificity of AD7c-NTP as a biochemical marker for Alzheimer's disease. JContemp Neurol 1998,2-6.
16. Ghanbari K and Ghanbari HA (1998). A sandwich enzyme immunoassay for measuring A.D7C-NTP as an Alzheimer's disease marker: AD7C test. J Clin Lab Anal 12,223-226.
17. Hermon M, Cairns N, Egly JM et al. (1998). Expression of DNA excision-repair-cross-complementing proteins p80 and p89 in brain of patients with Down Syndrome and Alzheimer's disease. Neurosci Lett 251,45-48.
18. Masliah E, Mallory M, DeTeresa R er aj. (1993). Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies. Brain Res 617,258-266.
19. Masliah E, Mallory M, Hansen L étal. (1991). Patterns of aberrant sprouting in Alzheimer's disease. Neuron 6,729-739.
20. Masliah E, Mallory M, Hansen L et al. (1994). Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci J.e«174,67-72.
21. Mon H and lhara Y (1991 ). Neurofibrillary tangles dystrophic neuntes (curly fibers) and abnormal phosphorylation of tau. Brain Pathol 1,273-277.
22. Onorato M, Mulvihill P, Connolly J er aj. (1989). Alteration of neuritic cytoarchitecture in Alzheimer disease. Prog Clin Biol Res 317, 781-789.
23. Ozturk M, de la Monte SM, Gross J and Wands JR (1989). Elevated levels of an exocrine pancreatic secretory protein in Alzheimer disease brain. Proc Natl Acad Sci USA 86, 419423.
24. Sohn YK, Ganju N, Bloch KD er aj. (1999). Neuritic sprouting with aberrant expression of the nitric oxide synthase III gene in neurodegenerative diseases. J Neurol Sci 162,133-151.
25. Su JH, Anderson AJ, Cummings BJ and Cotman CW (1994). Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReportS, 2529-2533.
26. Su JH, Deng G and Cotman CW (1997). Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage Bcl-2 expression and brain pathology. J Neuropathol Exp Neurol 56,86-93.
27. Tourtellotte WG and Van Hoesen GW (1991 ). The axonal origin of a subpopulation of dystrophic neurites in Alzheimer's disease. Neurosci Le«129,11-16.
28. Yamaguchi H, Nakazato Y, Shoji M étal. (1990). Ultrastructure of the neuropil threads in the Alzheimer brain: their dendritic origin and accumulation in the senile plaques. Ada Neuropathol 80,368-374.